1989
DOI: 10.1002/med.2610090304
|View full text |Cite
|
Sign up to set email alerts
|

1,4‐Dihydropyridines—a basis for developing new drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
82
0
2

Year Published

1998
1998
2009
2009

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 238 publications
(86 citation statements)
references
References 64 publications
0
82
0
2
Order By: Relevance
“…More than 25 years after the introduction of nifedipine (1), many DHP analogs have now been synthesized and numerous second-generation commercial products have appeared on the market [2].…”
Section: Introductionmentioning
confidence: 99%
“…More than 25 years after the introduction of nifedipine (1), many DHP analogs have now been synthesized and numerous second-generation commercial products have appeared on the market [2].…”
Section: Introductionmentioning
confidence: 99%
“…More than 20 years after the introduction of nifedipine (1), many DHP analogs have now been synthesized and numerous second-generation commercial products have appeared on the market (e.g. 2, 3) [2]. In recent years interest has also focused on aza-analogs such as dihydropyrimidines of type 4 (DHPMs) which show a very similar pharmacological profile to classical dihydropyridine calcium channel modulators [3][4][5][6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Research on 1,4-dihydropyridine (1,4-DHP) derivatives is of current interest due to the exceptional activities they exhibit as calcium antagonists, 1 which have been skillfully used in the treatment of cardiovascular diseases. 2,3 Substitution on the 1,4-DHP ring has been widely studied 4 because of the important effects that some substituents induce on the biological properties of these systems.…”
Section: Introductionmentioning
confidence: 99%